Funding for this research was provided by:
National Natural Science Foundation of China (82273246, 81872246)
Received: 22 December 2022
Accepted: 31 March 2023
First Online: 11 April 2023
: Studies involving human participants were reviewed and approved by the Ethics Committee of the Chinese PLA General Hospital. The patients/participants provided written informed consent to participate in the study. The animal study was reviewed and approved by the Institutional Animal Care and Use Committee of the Beijing Institute of Biotechnology.
: Not applicable.
: The authors declare that they have no competing interests.